Can physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial

Study protocol

Bibliographic Data

ID15358392
AuthorsKajal Gokal (0000-0002-2020-1876, Loughborough University, corresponding author), Fehmidah Munir (0000-0002-5585-0243, Loughborough University), Deborah Wallis, Deborah J Wallis (0000-0002-2216-1775, Loughborough University), Samreen Ahmed (Leicester Royal Infirmary), Ion Boiangiu (Leicester Royal Infirmary), Kiran Kancherla (Leicester Royal Infirmary)
Year2015
Volume15
Issue1
Pages160-161
Publication date2015-04-22
Open AccessYes
TypeARTICLE
VenueBMC Public Health (JOURNAL)
Journal identifiersISSN: 1471-2458 • E-ISSN: 1471-2458
PublisherBioMed Central (PUBLISHER • GB)
DOI10.1186/s12889-015-1751-0
PMID25903195
PMCIDPMC4446147
OpenAlexW1975413142
LanguageEN
References cited67

Evidence suggests chemotherapy treatment for breast cancer is associated with side effects such as cognitive impairment in domains of memory, attention, concentration and executive function. Cognitive impairments reported by patients have been associated with higher levels of emotional distress. To date, intervention studies to alleviate cognitive impairment associated with chemotherapy have focused on psycho-educational techniques or cognitive training. Studies have not yet considered physical activity as a potential for alleviating cognitive problems. Physical activity interventions are reported to be effective in alleviating emotional distress and fatigue in those with breast cancer. They have also been reported to improve cognitive functioning in the elderly, in those suffering with dementia and in children. We propose that physical activity could also help to alleviate cognitive impairments in women diagnosed with breast cancer. The study has been designed using a recently developed taxonomy of behaviour change techniques to reliably report the content of the intervention to allow future replication. This study will deliver a home-based moderate intensity walking intervention to women diagnosed with breast cancer mid-way through their chemotherapy treatment and will compare them to patients receiving usual care alone. The primary outcome measure for this intervention is changes in an objective measure of memory assessed using the Digit Span. Secondary outcome measures include: objective measures of executive function; attention; visual spatial skills; self report cognitive function; self-report fatigue; anxiety; depression; mood and self-esteem. As emotional distress has been associated with self-reporting of cognitive problems, this intervention will further test whether emotional distress mediates between the amount of walking undertaken during the intervention period and levels of self-reported cognitive functioning. The development of an effective intervention for preventing difficulties in emotional and cognitive functioning of cancer patients’ post-treatment will help to guide health care professionals to improve patients’ overall quality of life. It will also provide direction for future research, ultimately to improve the day to day functioning of breast cancer survivors. Current Controlled Trials ISRCTN50709297

Anxiety · Breast cancer · Cancer · Cognition · Distress · Mood · Physical therapy · Psychiatry · Psychological intervention · Psychosocial · Randomized controlled trial · Cancer survivorship and care · Cancer-related cognitive impairment studies · Clinical Psychology · Dementia and Cognitive Impairment Research · Medicine · Internal Medicine

Tools

Open DOISci-HubOpen Access